The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
1 other identifier
observational
690
1 country
1
Brief Summary
This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 14, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedJuly 21, 2022
July 1, 2022
2 months
July 14, 2022
July 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Demographic characteristics of patients with breast cancer
age, gender, residence, marital status
At the time of presentation
Risk factors of patients with breast cancer
age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index
At the time of presentation
Clinical presentation of patients with breast cancer
site and duration
At the time of presentation
Stage of the breast cancer
American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer
At the time of presentation
Histopathological characteristics of patients with breast cancer
tumor type, hormone receptor status, Ki-67, and grade
At the time of presentation
Study Arms (1)
Patients with breast cancer
Eligibility Criteria
All breast cancer patients registered at the Breast Clinic, at the Sindh Institute of Urology and Transplantation (SIUT), Karachi from March 2017 till December 2021 were included
You may qualify if:
- All patients diagnosed with breast cancer
You may not qualify if:
- The patients that were lost to follow-up after the first consultation and those consulting for a second opinion were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sindh Institute of Urology and Transplantation
Karachi, Sindh, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Murk Niaz
Sindh Institute of Urology and Transplantation
- PRINCIPAL INVESTIGATOR
Bushra Shirazi
Sindh Institute of Urology and Transplantation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Officer
Study Record Dates
First Submitted
July 14, 2022
First Posted
July 18, 2022
Study Start
February 28, 2022
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
July 21, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share